Emerging evidence highlights a complex interplay between treatments for diabetes and the risk of developing malignancies. Metabolic disturbances inherent to diabetes mellitus – notably hyperglycaemia, ...

Their study also explains why the cancer cells are resistant and how this resistance can be overcome: through concomitant pharmacotherapy or genetically improved CAR T-cells. Acute myeloid leukemia ...

Type 2 diabetes mellitus (T2DM) is becoming increasingly prevalent worldwide. Epidemiologic data suggest that T2DM is associated with an increased incidence and mortality from many cancers. The ...

At the 22nd Annual Conference of the National Comprehensive Cancer Network, in Orlando, Florida, Paul M. Cinciripini, PhD, of the University of Texas MD Anderson Cancer Center delivered a presentation ...